Skip to content
Business

ASML Posts Record €11.7bn Quarter and Warns Supply Will Not Meet AI Demand

ASML reported record third-quarter sales of €11.7 billion, guided Q4 to €14.2 to €15.2 billion and said its planned supply for 2027 and 2028 will not fully meet AI-driven demand.

ASML's corporate headquarters building in Veldhoven, the Netherlands.
Photo: A ansems / Wikimedia Commons, public domain

ASML reported record third-quarter sales of €11.7 billion on Wednesday and said the production it has planned for both 2027 and 2028 will not be enough to meet customer demand, as chipmakers keep raising their equipment forecasts on the back of AI investment.

The Dutch maker of chip-making machines, the only supplier of the extreme ultraviolet (EUV) lithography systems used to produce the most advanced chips, also guided fourth-quarter sales of €14.2 billion to €15.2 billion. Even the bottom of that range would be another quarterly record.

Upgrades and AI Orders Drive a Record Quarter

Net sales reached €11.66 billion in the three months to September, up from €9.33 billion in the second quarter and towards the high end of ASML's own guidance. Net income rose to €4.96 billion from €2.92 billion, and earnings per share to €12.95 from €7.59.

Q2 2026Q3 2026
Total net sales€9.3 billion€11.7 billion
Gross margin54.0%57.5%
Net income€2.9 billion€5.0 billion
Earnings per share€7.59€12.95
New lithography systems sold86113

ASML sold 113 new and 8 used lithography systems in the quarter, against 86 and 5 in the second quarter. Sales from its installed base management business, which services and upgrades machines already in customers' fabs, came in above guidance at €3.3 billion as chipmakers bought productivity upgrades to get more out of existing equipment. At 28 percent of total sales, that higher-margin business helped lift the gross margin to 57.5 percent, also above guidance and up from 54.0 percent three months earlier.

ASML's site in Veldhoven, the Netherlands, photographed in 2008.
ASML's site in Veldhoven, the Netherlands, photographed in 2008. Photo: HHahn / Wikimedia Commons, CC BY-SA 3.0

Demand Now Runs Ahead of Planned Capacity

The bigger message was about the next two years. Chief executive Christophe Fouquet said customers continue to raise both short- and medium-term equipment forecasts, driven mainly by their views on the size and duration of AI-related investment. Some are already asking to place orders for 2029 and even 2030.

With order momentum rising every quarter this year, ASML now expects that its supply as currently planned for 2027 and 2028 "will not fully meet the demand of our customers," Fouquet said. The company had already announced a 30 percent increase in 2027 capacity for its low-NA EUV and DUV immersion machines, and is now looking at ways to raise 2028 capacity beyond that. In the meantime, it is relying on productivity upgrades to give customers extra wafer output from machines they already own.

For a company whose machines take years to build, a supply shortfall is a double-edged message. It points to strong pricing power and a full order book, but it also means some customer spending could be delayed rather than captured if ASML cannot expand fast enough. The release did not give a figure for quarterly orders.

ASML: share price, chart and news

Guidance Points to a Strong Finish to 2026

For the fourth quarter, ASML expects a gross margin of about 57 percent, research and development costs of about €1.2 billion and selling, general and administrative costs of about €0.4 billion. For the full year it guided total net sales of €44 billion to €45 billion with a gross margin of around 56 percent.

The fourth-quarter range implies sales between about 22 and 30 percent higher than in the record third quarter, as deliveries ramp up towards the end of the year.

Cash Returned to Shareholders

The company bought back about €4.1 billion of its own shares in the third quarter under its 2026 to 2028 programme. It declared an interim dividend for 2026 of €1.88 per ordinary share, payable on 4 November. Cash and short-term investments rose to €12.7 billion at the end of September from €7.6 billion three months earlier.

The results give a read on Europe's exposure to the AI build-out. ASML's machines sit at the start of the chip supply chain, so its order commentary is closely watched as an early signal of how much the world's chipmakers plan to spend. Management was due to discuss the figures with investors on a call at 15:00 CET.

Sources

Related stories

Business

TSMC Profit Jumps 69% to a Record as 2nm Chips Ramp Up

TSMC's third-quarter net profit rose 68.7 percent to a record NT$763.06 billion as revenue of $46.72 billion beat guidance and 2nm chips reached 8 percent of sales.

Markets

Europe's AI Hardware Stocks Tumble as Nokia Falls 10% After Amodei Urges Slower AI

Nokia fell 10.13%, Infineon 7.72% and ASML 6.13% on 14 September after Anthropic's Dario Amodei urged AI firms to slow frontier model development and the heads of OpenAI and xAI…

Markets

European Shares End the Week at a Three-Week High as Ericsson and Nordex Rally

The STOXX 600 rose 0.67 percent to 644.43 on Friday, its best close in more than three weeks, as results from Nordex, Aixtron and Ericsson outweighed a fresh sell-off in AI stocks.

Markets

Nasdaq 100 Sinks 5.5% as Chipmakers Suffer Their Longest Losing Streak Since 2008

The Nasdaq 100 fell 5.49% this week as US chip stocks dropped for eight sessions in a row, the longest run since 2008, on AI spending doubts, $110 Brent and 5% yields. AMD lost…

Business

Québecor Makes a C$31bn Cash-and-Share Bid for Telus, Which Warns of Regulatory Risk

Québecor has offered C$6.35 in cash plus 0.17 of its own shares for each Telus share, a bid worth about C$31bn. The Telus board says the price falls short and the regulatory risk…

Business

Tyson Foods Shares Jump 8.7% as Beef Outlook Outweighs a $74m Quarterly Loss

Tyson Foods posted a $74m fourth-quarter net loss and adjusted EPS of $0.61, down 47%, yet its shares closed 8.7% higher on Monday as its 2027 beef outlook pointed to far smaller…

Business

Roche Wins FDA Approval for Breast Cancer Pill Wilserdly After 62% Cut in Progression Risk

The FDA approved Roche's all-pill Wilserdly combination for ESR1-mutated advanced breast cancer after it cut the risk of progression or death by 62%. A ruling on early-stage use is…

Business

ULA Loses Its First Mission as Vulcan Rocket Fails With 40 Amazon Leo Satellites on Board

United Launch Alliance's Vulcan rocket failed about 10 minutes after lift-off on Sunday, and all 40 Amazon Leo satellites were lost. Amazon fell 3.3% on Monday as space stocks…